The independent Institute for Clinical and Economic Review uses a cost-benefit analysis to figure out fair drug prices. It’s been called “Big Pharma’s biggest threat.” Carey Goldberg (@goldbergcarey)of WBUR reports.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org. 9(MDA4NjIwNTkwMDEzMjI4NDY0MjY4ZTBlNA004))